Shangli Cai
- Oncology top 2%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Immunology top 10%
- Topics
- Cancer Genomics and Diagnostics (35 papers)Cancer Immunotherapy and Biomarkers (35 papers)Lung Cancer Treatments and Mutations (23 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shangli Cai
99 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 990
- Molecular Biology 615
- Pulmonary and Respiratory Medicine 548
- Cancer Research 544
- Immunology 267
Countries citing papers authored by Shangli Cai
This map shows the geographic impact of Shangli Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangli Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangli Cai more than expected).
Fields of papers citing papers by Shangli Cai
This network shows the impact of papers produced by Shangli Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangli Cai. The network helps show where Shangli Cai may publish in the future.
Co-authorship network of co-authors of Shangli Cai
This figure shows the co-authorship network connecting the top 25 collaborators of Shangli Cai. A scholar is included among the top collaborators of Shangli Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangli Cai. Shangli Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinomabreakdown → | 354 |
| 11 | 5 | |
| 12 | 8 | |
| 13 | 6 | |
| 14 | 8 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | 141 | |
| 18 | 39 | |
| 19 | 90 | |
| 20 | 20 |
About Shangli Cai
Shangli Cai is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 110 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (35 papers), Cancer Immunotherapy and Biomarkers (35 papers) and Lung Cancer Treatments and Mutations (23 papers). The work is most often cited by research in Oncology (990 citations), Cancer Research (544 citations) and Biological Psychiatry (51 citations). Shangli Cai has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qiang Gao, Jia Fan, Yu Xu, Yuzi Zhang, Zhijie Wang, Fan Zhang, Chengcheng Li, Zijian Yang, Xuelian Ren and Xiaoying Wang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.